Australia markets closed

Tyra Biosciences, Inc. (TYRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.10+0.66 (+3.58%)
At close: 04:00PM EDT
19.10 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.00B
Enterprise value 627.54M
Trailing P/E 21.43
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.57
Enterprise value/revenue N/A
Enterprise value/EBITDA -6.95

Trading information

Stock price history

Beta (5Y monthly) 1.08
52-week change 332.18%
S&P500 52-week change 326.36%
52-week high 320.67
52-week low 310.38
50-day moving average 317.02
200-day moving average 315.02

Share statistics

Avg vol (3-month) 3130.19k
Avg vol (10-day) 3125.42k
Shares outstanding 552.54M
Implied shares outstanding 652.54M
Float 815.64M
% held by insiders 15.33%
% held by institutions 199.09%
Shares short (30 Apr 2024) 43.44M
Short ratio (30 Apr 2024) 427.64
Short % of float (30 Apr 2024) 411.82%
Short % of shares outstanding (30 Apr 2024) 46.55%
Shares short (prior month 28 Mar 2024) 42.83M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-16.66%
Return on equity (ttm)-23.63%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -87.54M
Net income avi to common (ttm)-75.45M
Diluted EPS (ttm)-1.69
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)382.46M
Total cash per share (mrq)7.28
Total debt (mrq)6.49M
Total debt/equity (mrq)1.66%
Current ratio (mrq)44.83
Book value per share (mrq)7.43

Cash flow statement

Operating cash flow (ttm)-62.32M
Levered free cash flow (ttm)-38.72M